Internalization and degradation of heparin binding growth factor-I by endothelial cells

Biochem Biophys Res Commun. 1988 Mar 30;151(3):957-64. doi: 10.1016/s0006-291x(88)80459-5.

Abstract

The fate of 125I-labeled heparin binding growth factor I (125I-HBGF-I) after binding to its cell surface receptor has been studied using murine lung capillary endothelial cells (LEII). Binding of 125I-HBGF-I to its receptor at 4 degrees C shows pH dependence with optimal binding at pH 6.5-7.5. The majority (approximately 80%) of 125I-HBGF-I bound to cells at 4 degrees C can be removed by washing with low pH medium, but rapidly becomes acid resistant upon shifting cells to 37 degrees C, with 50% of the 125I-HBGF-I becoming acid resistant after 20 minutes. Electrophoretic analysis of internalized 125I-HBGF-I shows that degradation begins approximately 2 hours after internalization with the appearance of two major labeled fragments of Mr 15,000 and Mr 10,000. Degradation of internalized 125I-HBGF-I is inhibited by the lysosomotropic agent chloroquine. These data suggest that cell-associated 125I-HBGF-I is rapidly internalized and directed to a lysosomal cellular compartment where it is slowly degraded.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Capillaries
  • Chloroquine / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Fibroblast Growth Factor 1
  • Growth Substances / metabolism*
  • Heparin / metabolism*
  • Hydrogen-Ion Concentration
  • Kinetics
  • Mice
  • Molecular Weight

Substances

  • Growth Substances
  • Fibroblast Growth Factor 1
  • Chloroquine
  • Heparin